Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Comment by jdstoxon Apr 03, 2019 11:08am
141 Views
Post# 29575954

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TrainWreck

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TrainWreckYeah, yeah, I agree, minedigger. What we need is more negative stuff from folks like you and regardless, and gfF. I think the made-up stuff like we saw in the last week works especially well.

And it's so easy for victims to empathize with each other. You have an audience, minedigger. After all these years, why would you want to change your message now. Bioasis is a loser and only the anger of you and a handful of public and private complainers can fix it. That's the message. We hate Bioasis and all who sail upon her.

Go for it, minedigger. Get your self-indulgent anger out there. See if, in the end, your way and 200 shares will get you a cup of coffe or whether doing it the company's way might get you a whole meal for 1 share. Your call, minedigger.

jdstox

John N. Davenport
Paid consultant at Bioasis since August, 2014
Tel: 250-448-1808
jd@jdstox.com
john@bioasis.us

.
.
Bullboard Posts